Patent Strategies and Competition Law in the Pharmaceutical Sector:Implications for Access to Medicines

Matthews, Duncan and Gurgula, Olga (2016). Patent Strategies and Competition Law in the Pharmaceutical Sector:Implications for Access to Medicines. European Intellectual Property Review, 38 (11), 661 - 667.

Abstract

Potentially anti-competitive practices, such as reverse payment agreements and strategic patenting, risk allowing pharmaceutical companies to block the entry of generic and innovative medicines, stifling competition and harming consumers. Such practices create particular challenges for developing countries. Policy coherence between the IP system and competition law must be strengthened in order to promote innovation and access to health technologies.

Divisions: Aston Business School > Law
Aston Business School
Full Text Link: https://qmro.qm ... 123456789/13672
Related URLs: http://www.swee ... px?recordid=460 (Publisher URL)
Published Date: 2016-05-16
Authors: Matthews, Duncan
Gurgula, Olga

Download

[img]

Version: Accepted Version

| Preview

Export / Share Citation


Statistics

Additional statistics for this record